Vista Pharmaceuticals: Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.2. Limited Review Report Quarter And Nine Months 31.12.2025.3. Any Other Business With The Permission Of The Chair.

Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2026 inter alia to consider and approve 1. Unaudited financial results for the quarter and nine months ended 31.12.2025.2. Limited Review Report quarter and nine months 31.12.2025.3. Any other business with the permission of the Chair.